Armonea Group   Report issue

For profit Phase 1
Founded: Belgium (1979)
Status: No NME R&D (1979)

Organization Overview

First Clinical Trial
2019
NCT03831399
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Armonea Group - La Saleta

Active Ingredients

Drugs in Phase 1 Trials (1)

leucine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Sarcopenia (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1